How do we manage post-OLT redundant bile duct?

Table 1 Patient data demographics

Men	12
Women	9
Average age (yr)	59.6
Indication for OLT
Hepatitis C	15
Cryptogenic	2
Steatohepatitis	1
Medication induced failure	1
Alcoholic cirrhosis	1
Autoimmune hepatitis	1
Average time (d) from OLT to ERCP	88.1
Indication for ERCP
Cholestatic LFT	21/21

LFT: liver function test; OLT: Orthotopic liver transplantation; ERCP: Endoscopic retrograde cholangiopancreatography.

Table 2 Interventions and results in 21 patients with redundant bile duct

Results	Resolved (n = 15)	Failure (n = 6)	P value
Men n (%)	8/15 (53.3)	4/6 (66.7)	0.577
Age1, yr	59.0 (39.0-70.0)	64.5 (50-75)	0.094
Hepatitis C indication n (%)	11/15 (73.3)	4/6 (66.7)	0.760
Time from OLT to ERCP1, d	14 (4-1059)	225 (8-865)	0.086
Total ERCP	3 (2-10)	3 (1-4)	0.492
Total biliary stents placed
Average stent per patient1	3 (0-15)	2 (0-4)	0.475
Average stent per session1	1.0 (0-1.5)	0.9 (0-1)	0.602
ERCP sessions for resolution			-
Single session	6/15	-
Two sessions	4/15	-
> Two sessions	5/15	-
Percutaneous biliary drainage		2	-
Choldocojejunostomy		2	-
T bili1, mg/dL	5.0 (0.3-37.3)	6.1 (1.2-34.9)	0.586
AST1	122 (34-444)	190 (40-1131)	0.392
ALT1	248 (42-668)	262 (58-1579)	0.846
Alk phos1	460 (109-1066)	345 (243-936)	0.907

¹Median (range). OLT: Orthotopic liver transplantation; ERCP: Endoscopic retrograde cholangiopancreatography; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase.